A valid prescription requires a telehealth consultation with a licensed provider. No medication is dispensed without clinical evaluation.

SS-31 (Elamipretide)
Targeted Mitochondrial Cardiolipin Protective Tetrapeptide

Compound Specifications
SS-31 (Elamipretide)
Targeted Mitochondrial Cardiolipin Protective Tetrapeptide
SS-31 (Elamipretide) 10mg in a 3mL vial is an innovative synthetic tetrapeptide that selectively targets and binds the inner mitochondrial membrane phospholipid cardiolipin, restoring electron transport chain efficiency, reducing ROS generation, and recharging ATP output.
Selectively concentrates on cardiolipin at the inner mitochondrial membrane, optimizing cristae structure, enhancing Cytochrome C electron transfer, and reversing age-related bioenergetic decline.
Documented Therapeutic Benefits
Results may vary. Individual outcomes depend on adherence, baseline health, and other factors.
Subcutaneous injection daily or 3-5 times weekly as directed by a healthcare provider.
Frequently Asked Clinical Questions
What makes SS-31 unique compared to general antioxidants?
Standard antioxidants merely scavenge ROS after they have already leaked. SS-31 targets cardiolipin at the source within the inner mitochondrial membrane to prevent excessive ROS formation and restore cristae architecture.